Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients

NCT00382694 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Fludarabine

Sponsor

Nordic Myeloma Study Group